ADRIAN LUJAN: Open Payments
NPI 1265043210 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,165 in 45 payments from 12 companies in 2025. Trend: 2023 $546 · 2024 $898 · 2025 $1,165
Food & beverage: $1,165
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $257 |
| UCB, Inc. | 8 | $169 |
| Organon LLC | 3 | $163 |
| Galderma Laboratories, L.P. | 3 | $151 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $110 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $97 |
| Novartis Pharmaceuticals Corporation | 3 | $79 |
| Incyte Corporation | 3 | $49 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| ABBVIE INC. | 1 | $27 |
Products named: TREMFYA, Bimzelx, NEMLUVIO, VTAMA, JOURNAVX, ILUMYA, OPZELURA, Winlevi.
Industry payments across TX — which companies pay providers there.
